Comparative performance of quantitative real-time PCR with melting curve analysis for drug resistance detection in pulmonary and extrapulmonary tuberculosis
Year: 2026
Type: article
Study design: Observational Study
Abstract: To evaluate the clinical utility of real-time PCR combined with melting curve analysis (MCA) technique for the rapid screening of drug-resistant tuberculosis (DR-TB). The clinical data of 873 patients with tuberculosis, including pulmonary and extrapulmonary tuberculosis, who underwent Mycobacterium tuberculosis (MTB) culture and drug susceptibility testing (DST), real-time PCR and MCA, admitted to Chengdu Public Health Clinical Medical Center between July 2024 and June 2025 were collected. The categorical phenotypic DST (BACTEC MGIT 960, critical concentrations) was used as the reference standard to assess the diagnostic performance of MCA for resistance detection in both pulmonary and extra-pulmonary specimens. In the samples collected from pulmonary tuberculosis patients, the sensitivities of MCA for rifampicin (RFP), isoniazid (INH), ethambutol (EMB), streptomycin (SM), and fluoroquinolones (FQs) resistance were 73.41%, 88.04%, 96.23%, 94.34%, and 85.71%, respectively, and the specificities were 97.49%, 98.47%, 96.66%, 97.44%, and 94.38%. The kappa values for agreement between MCA and the MIC were 0.76, 0.89, 0.78, 0.88, and 0.69, respectively, indicating good to excellent concordance. In extrapulmonary specimens (n = 102), the sensitivity of MCA for RFP, INH, EMB, SM, and FQs resistance was 94.74%, 90.48%, 16.67%, 50.00%, and 83.33%, respectively, with specificities of 92.77%, 96.30%, 92.71%, 86.00%, and 93.75%. The kappa values were 0.79, 0.85, 0.08, 0.09, and 0.55, respectively. There was no statistically significant difference between the two methods in the detection rate for INH (χ2 = 3.361, P = 0.067); there were significant differences in the detection of resistance to RFP, EMB, SM, and FQs (χ2 RF = 9.191, P = 0.002; χ2 EMB = 13.921, P < 0.001; χ2 SM = 13.921, P < 0.001; χ2 FQs = 17.965, P < 0.001). MCA is a reliable rapid screening tool for pulmonary tuberculosis, but its use in extrapulmonary specimens is limited, particularly for EMB and SM, for which confirmatory testing remains essential. Not applicable.
Source: BMC Infectious Diseases
Institution: Public Health Clinical Center of Chengdu
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: drug-resistant tuberculosis, Mycobacterium tuberculosis, melting curve analysis, real-time PCR, extrapulmonary tuberculosis, pulmonary tuberculosis, isoniazid resistance, rifampicin resistance, ethambutol resistance, streptomycin resistance, fluoroquinolone resistance, drug susceptibility testing, diagnostic accuracy, molecular tuberculosis diagnosis
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W7226459520
